1. Home
  2. VERI vs ICCC Comparison

VERI vs ICCC Comparison

Compare VERI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veritone Inc.

VERI

Veritone Inc.

HOLD

Current Price

$1.35

Market Cap

80.2M

Sector

Technology

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$9.94

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERI
ICCC
Founded
2014
1982
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.2M
93.1M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
VERI
ICCC
Price
$1.35
$9.94
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
★ 2.4M
11.1K
Earning Date
04-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.41
Revenue
★ $92,637,000.00
$26,493,169.00
Revenue This Year
$52.20
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
★ N/A
$24.23
Revenue Growth
N/A
★ 51.64
52 Week Low
$0.76
$4.52
52 Week High
$9.42
$12.10

Technical Indicators

Market Signals
Indicator
VERI
ICCC
Relative Strength Index (RSI) 62.80 47.52
Support Level $1.27 $9.39
Resistance Level $1.56 $10.16
Average True Range (ATR) 0.10 0.29
MACD 0.03 0.03
Stochastic Oscillator 77.01 67.66

Price Performance

Historical Comparison
VERI
ICCC

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: